What's Driving The Future Of Biopharma And Outsourcing Strategies?

In this interview from the BioProcess Theater at BIO 2025 in Boston, AGC Biologics CBO Christoph Winterhalter talks about the rapidly changing landscape of complex drug development. He highlights the key elements for success, especially for drugs made with molecules other than traditional antibodies.

Winterhalter also shares his insights on building a strong partnership between a drug sponsor and supplier, emphasizing the importance of transparency and cultural alignment. He explains how sponsors can use these relationships to speed up the innovation process.

The discussion also touches on how geopolitical factors are reshaping the global pharmaceutical market. Winterhalter explores the challenges and opportunities this creates for companies that need to be fast and flexible, and he provides options for avoiding expensive tariffs.